Stay updated on Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial
Sign up to get notified when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.

Latest updates to the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedAdded a dedicated Locations section listing Seongnam-si and updated the page to Revision v3.3.3; removed the HHS Vulnerability Disclosure reference and the Seongnam-si Locations reference.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page now shows Revision: v3.3.1, replacing the previous v3.2.0. This appears to be a minor update with no changes to the study data or eligibility criteria.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page no longer displays the operating-status notice about government funding. Trial content and study details remain unchanged.SummaryDifference0.4%

- Check67 days agoChange DetectedThe update appears to consist of minor UI refinements and layout adjustments, with no changes to core study content. Core details such as eligibility criteria, outcomes, and enrollment remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check96 days agoChange DetectedVersion update from v3.0.2 to v3.2.0 indicating a new release; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.